Glenmark Pharmaceuticals Ltd Quarterly Result
Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
Net Profit - Last Quarter
Glenmark Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Glenmark Pharmaceuticals Ltd for the Mar '26 is ₹ 3959 crore as compare to the Dec '25 revenue of ₹ 3945 crore.
- This represent the growth of 0.37% The ebitda of Glenmark Pharmaceuticals Ltd for the Mar '26 is ₹ 578.28 crore as compare to the Dec '25 ebitda of ₹ 729.88 crore.
- This represent the decline of -20.77% The net profit of Glenmark Pharmaceuticals Ltd for the Mar '26 is ₹ 301.32 crore as compare to the Dec '25 net profit of ₹ 403.23 crore.
- This represent the decline of -25.27%.
Glenmark Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Glenmark Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 08 Jun 2026 | 2178.55 |
| 05 Jun 2026 | 2165.5 |
| 04 Jun 2026 | 2181.45 |
| 03 Jun 2026 | 2173.55 |
| 02 Jun 2026 | 2184.9 |
| 01 Jun 2026 | 2201.2 |
| 29 May 2026 | 2274.25 |
| 27 May 2026 | 2382.65 |
| 26 May 2026 | 2351.25 |
| 25 May 2026 | 2335.6 |
Historical Revenue of Glenmark Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Glenmark Pharmaceuticals Ltd
Historical EBITDA of Glenmark Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Glenmark Pharmaceuticals Ltd
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd News Hub
Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1
Read more
21 Aug 24
Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session
Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163
Read more
19 Aug 24
Glenmark Pharma gains after American subsidiary launches Olopatadine generic
The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L
Read more
19 Aug 24
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio
Read more
19 Aug 24
Document
Popular Search
About Glenmark Pharmaceuticals Ltd
- Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
- The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
- It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
- The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
- Its branded generics business has a significant presence in markets across emerging economies including India.
FAQs for Quarterly Results of Glenmark Pharmaceuticals Ltd
What key financial metrics are included in Glenmark Pharmaceuticals Ltd's quarterly results?
When does Glenmark Pharmaceuticals Ltd announce its quarterly results?
How does Glenmark Pharmaceuticals Ltd's quarterly performance impact its stock price?
What is the impact of Glenmark Pharmaceuticals Ltd's quarterly results on dividends?
Are there any special announcements usually made during Glenmark Pharmaceuticals Ltd's quarterly results?
